WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of VIROVYVQCGLCII-UHFFFAOYSA-N.svg
tripsit

amobarbital

Vérifier sur tripsit

psychonaut

Amobarbital

Vérifier sur psychonaut

isomerdesign

Amobarbital

Vérifier sur isomerdesign

pubchem

Amobarbital

Vérifier sur pubchem

drugmap

Amobarbital

Vérifier sur drugmap

wiki

Amobarbital

Vérifier sur wiki

Data

InChI: InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)

Synonymes: Eunoctal,component of Q-Caps,5-Ethyl-5-isopentylbarbituric acid,5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, Component of Q-Caps,CBDivE_006514,AMOBARBITAL [INN],Amobarbital [USP:INN:BAN:JAN], Amital,Amobarbital 1.0 mg/ml in Methanol,Dorlotyn, Isoamylethylbarbituric acid,5-Ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione,5-Ethyl-5-isoamylbarbituric acid,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-,AMOBARBITAL [JAN],Dormytal,Barbituric acid, 5-ethyl-5-isoamyl-,Sumital,NSC-10815,5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,component of Dexamyl (Salt/Mix),DTXSID9020081,Amylbarbitone,5-Ethyl-5-isopentyl-2,4,6(1H,3H,5H)-pyrimidinetrione #, Talamo, Amobarbitalum,5-Ethyl-5-(3-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione,KBio1_000994,CCRIS 5454,DSSTox_CID_81, Pentymal,AMOBARBITAL [VANDF],NSC 10815,Amobarbitalum,DSSTox_GSID_20081,component of Dexamyl,Amylobarbitone,IDI1_000994,WLN: T6VMVMV FHJ F2 F2Y1&1,Amobarbitalum [INN-Latin], Ethylisopentylbarbituric acid, 5-Ethyl-5-isoamylmalonyl urea, 5-Ethyl-5-isopentylbarbituric acid,Stadadorm,DivK1c_000994,SCHEMBL15364946, Amybal, Amasust, Amobarbitalum [INN-Latin],Barbituric acid, 5-ethyl-5-isopentyl-,HSDB 3286, Component of Dexamyl, Stadadorm,Amasust,VIROVYVQCGLCII-UHFFFAOYSA-,CHEBI:2673, 5-Ethyl-5-(3-methylbutyl)barbituric acid,AMOBARBITAL [WHO-DD],component of 15-90 (Salt/Mix), Dormytal,NINDS_000994,Amobarbital 0.1 mg/ml in Methanol, Amobarbitale,DSSTox_RID_75353,Tox21_112866, Isomytal,5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione, Amylbarbitone, Sumital,AMAL, Sednotic,Mylodorm,UNII-GWH6IJ239E,5-Ethyl-5-isoamylmalonyl urea,Somnal,Sednotic,Amobarbital, Somnal, Isomyl, Mylodorm,Barbamil, Schiwanox,2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione, Amylobarbital,GWH6IJ239E,Dexamyl (Salt/Mix),NSC32406, Amobarbitone,NSC10815,Amobarbitale [DCIT], Amobarbital suppository dosage form,C07536,5-Ethyl-5-isopentylbarbitursaeure, Amytal, Robarb,Isoamylethylbarbituric acid, Barbamyl,Amobarbital (JP17/INN),57-43-2, Amobarbital [INN:JAN],Amybal,Isomytal (TN),SCHEMBL43780, 5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,amobarbital,Barbamyl, Binoctal, Amobarbital (JP15/INN),Talamo,Amytal,D00555,NCGC00247711-01, Barbamyl acid,AMOBARBITAL [MI],Schiwanox, 5-Ethyl-5-isopentylbarbitursaeure,Isomytal,component of Q-Caps (Salt/Mix),Oprea1_587446,Amobarbitale, Amylobarbitone,DEA No. 2125, 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,5-Ethyl-5-(3-methylbutyl)barbituric acid,component of 15-90, Isomytal (TN),BIDD:PXR0091,5-Isoamyl-5-ethylbarbituric acid,057A558, Amospan,DB01351,NSC-120800,AMOBARBITAL [HSDB],Isomyl,Amospan,NSC120800, Component of 15-90,Binoctal,AMOBARBITAL CII [USP-RS],Barbamyl acid,EINECS 200-330-7,Q415850, 5-Isoamyl-5-ethylbarbituric acid,Pentymalum,AMOBARBITAL [EP IMPURITY],NSC-32406,Ethylisopentylbarbituric acid, Component of Amo-Dextrosule,Amobarbital cii,AMOBARBITAL [MART.],Amobarbitone,Pentymal, Amobarbitale [DCIT],Amobarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,CAS-57-43-2, Barbamil, Dorlotyn, Eunoctal,Amital,component of Amo-Dextrosule,Robarb,ZINC4811698,CHEMBL267894,component of Amo-Dextrosule (Salt/Mix),Amylobarbital, Pentymalum


Estimated data

Solubility: -2.065 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 38.1% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.